Jul 11, 2024
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Molecular Pharming Market Size, Share & Trends Analysis Report By Crop Source (Maize, Barley, Tobacco, Safflower, Rice, Alfalfa), By Technology (Gene Gun, Agroinfiltration, Electroporation, Agrobacterium-Mediated Gene Transfer), By Application (Recombinant Antibodies, Hormones, Vaccines, Industrial Enzymes, Proteins & Protein-Based Materials, Technical Reagents, Nutritional Products), By End User (Biotechnology & Pharmaceutical Companies, Contract Manufacturing Organizations)- Market Outlook And Industry Analysis 2031"
The Global Molecular Pharming Market is valued at US$ 457.7 Mn in 2023, and it is expected to reach US$ 1,299.8 Mn by 2031, with a CAGR of 15.3% during the forecast period of 2024-2031.
Request Complete FREE Sample Report Click Here: https://insightaceanalytic.com/request-sample/1712
Molecular pharming, also known as plant molecular farming, is a biotechnological method leveraging genetically modified plants or organisms to produce valuable proteins, pharmaceuticals, and other high-value products. This approach involves the introduction of recombinant DNA into plants or animal cells to enable the expression of specific proteins or compounds. Molecular pharming finds extensive applications across pharmaceuticals, industrial manufacturing, and agriculture. It enables the economical production of therapeutic proteins, enzymes, monoclonal antibodies, and innovative products like edible vaccines and plantibodies (plant-derived antibodies). Moreover, it supports the synthesis of industrial enzymes and chemicals, alongside advancements in crop nutrition and protection.
Molecular pharming offers diverse applications in pharmaceuticals by facilitating cost-effective production of vital medicines and antibodies, meeting global healthcare demands. In industrial settings, it contributes to the efficient synthesis of enzymes and chemicals crucial for various manufacturing processes. Agricultural applications of molecular pharming are pivotal in enhancing crop resilience, nutrition, and sustainability, aligning with increasing environmental concerns and the shift towards sustainable farming practices. The market for molecular pharming is poised for significant growth driven by these broad applications and the continuous demand for innovative biotechnological solutions. As sustainability becomes increasingly critical, there is a growing adoption of molecular pharming technologies to support efficient agricultural practices and meet global healthcare needs, indicating robust market expansion in the foreseeable future.
Drivers-
Advancements in genetic engineering techniques, particularly with innovations like CRISPR, are revolutionizing molecular pharming by expanding capabilities in producing novel treatments and therapies. The pharmaceutical industry's increasing partnerships with biotech firms and research institutes further propel demand for these technologies, promising more cost-effective and scalable drug manufacturing processes compared to traditional methods. Molecular pharming stands out for its ability to produce complex pharmaceuticals such as therapeutic proteins and biopharmaceuticals that are challenging to synthesize chemically.
Moreover, its flexibility in production locations, whether in fields or specialized facilities, responds to global needs for accessible and sustainable drug production. The growing emphasis on sustainability in agriculture due to environmental concerns also drives adoption, as molecular pharming supports enhanced crop nutrition and protection, aligning with modern healthcare demands for innovative and affordable medicines.
Challenges:
Molecular pharming encounters challenges such as high development costs, complexities in maintaining genetic stability, and regulatory uncertainties, which hinder widespread adoption and market growth.
Regional Trends:
North America benefits from a strong network of distribution channels and efficient supply chain management, ensuring prompt delivery of molecular pharming products to healthcare providers and patients. The region's high healthcare expenditure and favorable reimbursement policies further bolster market growth by enhancing accessibility to advanced molecular pharming therapies. Major players such as Medicago, Fraunhofer IME, and iBio contribute significantly to industry expansion through substantial investments in research, development, and commercialization. Additionally, the supportive regulatory environment for biologics and biosimilars in the US and Canada, guided by agencies like the FDA, facilitates the approval and adoption of molecular pharming technologies, solidifying North America's position as a leading market in the field.
By Crop Source:
By Technology:
By Application:
By End User:
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
Sales
Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
info@insightaceanalytic.com
North America: +1 551 226 6109
Asia: +91 79 72967118
